MXPA03005325A - Metodo para identificar sustancias que influencian positivamente las condiciones inflamatorias de las enfermedades cronicas inflamatorias de las vias respiratorias. - Google Patents

Metodo para identificar sustancias que influencian positivamente las condiciones inflamatorias de las enfermedades cronicas inflamatorias de las vias respiratorias.

Info

Publication number
MXPA03005325A
MXPA03005325A MXPA03005325A MXPA03005325A MXPA03005325A MX PA03005325 A MXPA03005325 A MX PA03005325A MX PA03005325 A MXPA03005325 A MX PA03005325A MX PA03005325 A MXPA03005325 A MX PA03005325A MX PA03005325 A MXPA03005325 A MX PA03005325A
Authority
MX
Mexico
Prior art keywords
leu
protein
gly
val
group
Prior art date
Application number
MXPA03005325A
Other languages
English (en)
Spanish (es)
Inventor
Kraut Norbert
Original Assignee
Bohenringer Ingelheim Pharma G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bohenringer Ingelheim Pharma G filed Critical Bohenringer Ingelheim Pharma G
Publication of MXPA03005325A publication Critical patent/MXPA03005325A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/5055Cells of the immune system involving macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
MXPA03005325A 2000-12-22 2001-12-15 Metodo para identificar sustancias que influencian positivamente las condiciones inflamatorias de las enfermedades cronicas inflamatorias de las vias respiratorias. MXPA03005325A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25787800P 2000-12-22 2000-12-22
PCT/EP2001/014838 WO2002052270A2 (en) 2000-12-22 2001-12-15 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Publications (1)

Publication Number Publication Date
MXPA03005325A true MXPA03005325A (es) 2004-12-03

Family

ID=22978162

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005325A MXPA03005325A (es) 2000-12-22 2001-12-15 Metodo para identificar sustancias que influencian positivamente las condiciones inflamatorias de las enfermedades cronicas inflamatorias de las vias respiratorias.

Country Status (6)

Country Link
US (1) US20020150958A1 (enExample)
EP (1) EP1346228A2 (enExample)
JP (1) JP2004516038A (enExample)
CA (1) CA2430610A1 (enExample)
MX (1) MXPA03005325A (enExample)
WO (1) WO2002052270A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021360A1 (en) * 2001-04-24 2007-01-25 Nyce Jonathan W Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase
WO2003014745A2 (en) * 2001-08-06 2003-02-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for identifying anti-inflammatory drugs
WO2004070058A1 (en) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of copd
WO2005017113A2 (en) * 2003-08-11 2005-02-24 Lovelace Respiratory Research Institute, Et Al. Metalloproteinase gene polymorphism in copd
WO2007044622A1 (en) 2005-10-07 2007-04-19 Yale University Use of mif and mif pathway agonists
FR2904001A1 (fr) * 2006-07-19 2008-01-25 Galderma Res & Dev S N C Snc Modulateurs de la udp-glucose ceramide glucosyltransferase dans le traitement de l'acne ou de l'hyperkeratinisation
US20150309012A1 (en) * 2012-12-07 2015-10-29 Baxter International Inc. Anti-mif antibody cell migration assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080407A (en) * 1993-05-17 2000-06-27 The Picower Institute For Medical Research Diagnostic assays for MIF
AU1235601A (en) * 1999-10-29 2001-05-14 Cytokine Pharmasciences, Inc. Compounds having mif antagonist activity

Also Published As

Publication number Publication date
EP1346228A2 (en) 2003-09-24
US20020150958A1 (en) 2002-10-17
WO2002052270A2 (en) 2002-07-04
JP2004516038A (ja) 2004-06-03
WO2002052270A3 (en) 2003-03-13
CA2430610A1 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
Lanza et al. Functional assessment of isolated mitochondria in vitro
Delsite et al. Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells
Shi et al. Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation
CN103013940B (zh) 具有增加的稳定性的突变型乳酸氧化酶以及涉及其的产品、方法和用途
Jaspers et al. Vanadium-Induced κ B-Dependent Transcription Depends upon Peroxide-Induced Activation of the p38 Mitogen-Activated Protein Kinase
KR20070033435A (ko) 화합물을 동정하기 위한 대사 방법
MXPA03005325A (es) Metodo para identificar sustancias que influencian positivamente las condiciones inflamatorias de las enfermedades cronicas inflamatorias de las vias respiratorias.
Derbyshire et al. Nucleotide regulation of soluble guanylate cyclase substrate specificity
IL196874A (en) Filtration method for operators of soluble guanylate cyclase with iron are oxidized
Krysan et al. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress
Yan et al. Hes-1, a known transcriptional repressor, acts as a transcriptional activator for the human acid α-glucosidase gene in human fibroblast cells
Liang et al. Alternative promoters determine tissue-specific expression profiles of the human microsomal epoxide hydrolase gene (EPHX1)
Serio et al. Sp1 and Sp3 function as key regulators of leukotriene C4 synthase gene expression in the monocyte-like cell line, THP-1
Ivanova et al. Inhibition of thioredoxin reductase activity reduces the antioxidant defense capacity of human pluripotent stem cells under conditions of mild but not severe oxidative stress
Joguchi et al. Overexpression of VDUP1 mRNA sensitizes HeLa cells to paraquat
Ott et al. High-resolution transcriptional profiling of chemical-stimulated dendritic cells identifies immunogenic contact allergens, but not prohaptens
Hashimoto et al. 5-Amino-4-imidazolecarboxamide riboside confers strong tolerance to glucose starvation in a 5′-AMP-activated protein kinase-dependent fashion
US20020160438A1 (en) Method for identifying compounds which positively influence inflammatory conditions
CN118812576A (zh) 一种检测细胞色素氧化酶cyp2d6的荧光探针及其应用
EP1346225A2 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
WO2003014745A2 (en) Method for identifying anti-inflammatory drugs
Table Supporting Information S1. Detailed Methods.
JP2004500556A (ja) 化学発光を使用する遺伝子用バイオセンサ
WO2001009375A2 (en) Inducible screen for drug discovery
KR20050016494A (ko) 진단 및 치료 표적으로 사용되는 sgk 및 nedd